|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
JP2001514885A
(en)
|
1997-08-19 |
2001-09-18 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
70 human secreted proteins
|
|
WO1999013078A1
(en)
|
1997-09-12 |
1999-03-18 |
Biogen, Inc. |
Cysteine rich receptors-train
|
|
US6849719B2
(en)
|
1997-09-17 |
2005-02-01 |
Human Genome Sciences, Inc. |
Antibody to an IL-17 receptor like protein
|
|
US6635443B1
(en)
*
|
1997-09-17 |
2003-10-21 |
Human Genome Sciences, Inc. |
Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein
|
|
US20030039648A1
(en)
|
1998-09-16 |
2003-02-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US20030130182A1
(en)
*
|
1997-11-05 |
2003-07-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
ES2292242T5
(en)
|
1998-05-15 |
2011-05-04 |
Genentech, Inc. |
THERAPEUTIC USES OF IL-17 HOMOLOGICAL POLYPEPTIDES.
|
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
|
US6291663B1
(en)
*
|
1999-03-03 |
2001-09-18 |
Board Of Trustees Of The University Of Arkansas |
TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
|
|
US7465785B2
(en)
|
1999-03-08 |
2008-12-16 |
Genentech, Inc. |
Polypeptide encoded by a nucleic acid over-expressed in melanoma
|
|
US8133734B2
(en)
|
1999-03-16 |
2012-03-13 |
Human Genome Sciences, Inc. |
Kit comprising an antibody to interleukin 17 receptor-like protein
|
|
AU5007200A
(en)
*
|
1999-05-13 |
2000-12-05 |
Medical Research Council |
Ox2 receptor homologs
|
|
EP1623993A3
(en)
*
|
1999-09-01 |
2006-06-07 |
Genetech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001036604A2
(en)
|
1999-11-18 |
2001-05-25 |
Corvas International, Inc. |
Nucleic acids encoding endotheliases, endotheliases and uses thereof
|
|
DK1897945T3
(en)
*
|
1999-12-23 |
2012-05-07 |
Genentech Inc |
IL-17 homologous polypeptides and therapeutic uses thereof.
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
WO2002000857A2
(en)
*
|
2000-06-15 |
2002-01-03 |
Millennium Pharmaceuticals, Inc. |
53320, a human acyltransferase and uses therefor
|
|
US7094566B2
(en)
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
AU2001259271A1
(en)
|
2000-04-28 |
2001-11-12 |
Millennium Pharmaceuticals, Inc. |
14094, a novel human trypsin family member and uses thereof
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
ATE385504T1
(en)
|
2000-06-06 |
2008-02-15 |
Bristol Myers Squibb Co |
NUCLEIC ACIDS AND POLYPEPTIDES RELATED TO B7 AND THEIR USES FOR IMMUNE MODULATION
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
JP2004500872A
(en)
*
|
2000-06-22 |
2004-01-15 |
バイオジェン インコーポレイテッド |
GP354 nucleic acids and polypeptides
|
|
US20020061574A1
(en)
*
|
2000-09-01 |
2002-05-23 |
Rachel Meyers |
16658, 14223, and 16002, novel human kinases and uses therefor
|
|
EP1294885A2
(en)
*
|
2000-06-30 |
2003-03-26 |
Amgen, Inc. |
B7-like molecules and uses thereof
|
|
JP2004527210A
(en)
|
2000-08-02 |
2004-09-09 |
ザ ジョンズ ホプキンス ユニバーシティー |
Evaluation method of endothelial cell expression pattern
|
|
AU2001229503A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Human Genome Sciences, Inc. |
17 human secreted proteins
|
|
AU2001294703A1
(en)
*
|
2000-09-25 |
2002-04-08 |
Millennium Pharmaceuticals, Inc. |
32624 a novel human udp-glucuronosyl and glycosyl transferase family member and uses thereof
|
|
HUP0600776A2
(en)
|
2000-11-14 |
2007-01-29 |
Bristol Myers Squibb Co |
A human serpin secreted from lymphoid cells lsi-01
|
|
DE10106835A1
(en)
*
|
2001-02-14 |
2002-09-05 |
Basf Lynx Bioscience Ag |
Signal transduction proteins 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences
|
|
JPWO2002064769A1
(en)
*
|
2001-02-15 |
2004-06-17 |
塩野義製薬株式会社 |
New disease markers
|
|
EP1873245A1
(en)
*
|
2001-02-28 |
2008-01-02 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
JP2004533222A
(en)
*
|
2001-03-12 |
2004-11-04 |
インサイト・ゲノミックス・インコーポレイテッド |
Immunoglobulin superfamily proteins
|
|
CA2443123A1
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
AU2002258780A1
(en)
|
2001-04-11 |
2002-10-28 |
Bristol-Myers Squibb Company |
Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
|
|
US7125663B2
(en)
|
2001-06-13 |
2006-10-24 |
Millenium Pharmaceuticals, Inc. |
Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
|
|
CA2451271A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Alexander V. Lukashin |
Pancam nucleic acids and polypeptides
|
|
WO2003004530A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human somatostatin receptor-like protein
|
|
JP2005502332A
(en)
*
|
2001-07-26 |
2005-01-27 |
ジェンセット ソシエテ アノニム |
GMG-2 polynucleotides and polypeptides and uses thereof
|
|
JP4702819B2
(en)
|
2001-08-01 |
2011-06-15 |
生化学工業株式会社 |
Chondroitin synthase
|
|
US7262026B2
(en)
|
2001-08-23 |
2007-08-28 |
Japan Science And Technology Agency |
Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same
|
|
ES2390531T3
(en)
|
2001-09-18 |
2012-11-13 |
Genentech, Inc. |
Compositions and procedures for the diagnosis and treatment of tumor
|
|
WO2003025162A2
(en)
*
|
2001-09-20 |
2003-03-27 |
Bayer Healthcare Ag |
Regulation of human prolyl 4-hydroxylase alpha subunit precursor
|
|
EP1469877A4
(en)
*
|
2001-11-02 |
2008-08-20 |
Tanox Inc |
B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
|
|
AU2002359815A1
(en)
|
2001-12-19 |
2003-07-09 |
Immunex Corporation |
C-type lectin polypeptide, polynucleotide and methods of making and use thereof
|
|
DE10211088A1
(en)
*
|
2002-03-13 |
2003-09-25 |
Ugur Sahin |
Gene products differentially expressed in tumors and their use
|
|
MXPA04010091A
(en)
*
|
2002-04-17 |
2004-12-13 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor.
|
|
EP2275118A3
(en)
|
2002-05-29 |
2011-10-19 |
DeveloGen Aktiengesellschaft |
Pancreas-specific proteins
|
|
DE60319529T2
(en)
*
|
2002-05-31 |
2008-10-23 |
Seikagaku Corp. |
CHONDROITINE SYNTHETASE AND ENZYME-CODING NUCLEIC ACID
|
|
AU2003241979A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Hidetoshi Inoko |
Inflammatory skin disease-related slurp-2 gene and utilization thereof
|
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
CA2497337A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel composition and methods for the treatment of psoriasis
|
|
DE10242016A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Esplora GmbH c/o TU Darmstadt Institut für Biochemie |
Identifying blood-brain barrier protein, useful e.g. as drug transporter and for treatment or diagnosis, by subtractive hybridization using cDNA from brain capillary cells
|
|
DE10254601A1
(en)
*
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Gene products differentially expressed in tumors and their use
|
|
AU2003292774A1
(en)
*
|
2002-12-26 |
2004-07-22 |
Takeda Pharmaceutical Company Limited |
Novel proteins and use thereof
|
|
AU2003302753A1
(en)
*
|
2002-12-27 |
2004-08-10 |
Laboratoires Serono Sa |
Novel fibrillin-like polypeptides
|
|
US20060089297A1
(en)
*
|
2003-01-16 |
2006-04-27 |
Herr John C |
Sperm specific lysozyme-like proteins
|
|
US7312197B2
(en)
|
2003-02-24 |
2007-12-25 |
University Of Maryland, Baltimore |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
|
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
KR100835786B1
(en)
|
2003-07-08 |
2008-06-09 |
제넨테크, 인크. |
- il-17a/f heterologous polypeptides and therapeutic uses thereof
|
|
AU2004266246A1
(en)
|
2003-08-14 |
2005-03-03 |
Dyax Corp. |
Endotheliase-2 ligands
|
|
US7825235B2
(en)
|
2003-08-18 |
2010-11-02 |
Isis Pharmaceuticals, Inc. |
Modulation of diacylglycerol acyltransferase 2 expression
|
|
WO2005061704A1
(en)
*
|
2003-12-24 |
2005-07-07 |
Takeda Pharmaceutical Company Limited |
Preventive/remedy for cancer
|
|
DE102004024617A1
(en)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
|
WO2006014335A2
(en)
|
2004-07-02 |
2006-02-09 |
Genentech, Inc. |
Compositions and methods for treatment of non-hodgkin’s lymphoma
|
|
CN101014245A
(en)
|
2004-08-03 |
2007-08-08 |
比奥根艾迪克Ma公司 |
Taj in neuronal function
|
|
US7709611B2
(en)
|
2004-08-04 |
2010-05-04 |
Amgen Inc. |
Antibodies to Dkk-1
|
|
US7544659B2
(en)
|
2004-08-13 |
2009-06-09 |
Genentech, Inc. |
Promotion of axonal regeneration
|
|
JP2008532516A
(en)
*
|
2005-03-11 |
2008-08-21 |
ジェネンテック・インコーポレーテッド |
Gene disruption, composition, and related methods
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
NZ568015A
(en)
|
2005-12-08 |
2012-03-30 |
Medarex Inc |
Human monoclonal antibodies to O8E
|
|
WO2007107774A2
(en)
*
|
2006-03-22 |
2007-09-27 |
Cartela R & D Ab |
Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
|
|
US20090288176A1
(en)
*
|
2006-04-19 |
2009-11-19 |
Genentech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
|
EP2057177B1
(en)
|
2006-08-04 |
2012-11-21 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to diacylglycerol acyltransferase 1
|
|
EP2069793B9
(en)
|
2006-08-29 |
2017-08-16 |
Oxford BioTherapeutics Ltd |
Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer
|
|
US8058014B2
(en)
|
2006-09-29 |
2011-11-15 |
University Of Maryland, Baltimore |
Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2
|
|
CN104628855A
(en)
|
2008-05-05 |
2015-05-20 |
诺维莫尼公司 |
Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
|
|
CA2726804C
(en)
*
|
2008-06-02 |
2021-12-28 |
Dana-Farber Cancer Institute, Inc. |
Xbp1, cd138, and cs1 peptides
|
|
MX2011009220A
(en)
|
2009-03-05 |
2011-09-28 |
Medarex Inc |
Fully human antibodies specific to cadm1.
|
|
AU2010244142B2
(en)
|
2009-05-05 |
2016-07-21 |
Novimmune Sa |
Anti-IL-17F antibodies and methods of use thereof
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
EP2914278B1
(en)
|
2012-11-05 |
2021-06-02 |
Dana-Farber Cancer Institute, Inc. |
Xbp1, cd138, and cs1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions
|
|
US10093736B2
(en)
|
2012-11-13 |
2018-10-09 |
Biontech Ag |
Agents for treatment of claudin expressing cancer diseases
|
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
ES2917181T3
(en)
|
2015-07-10 |
2022-07-07 |
Ionis Pharmaceuticals Inc |
Diacylglycerol acyltransferase 2 (DGAT2) modulators
|